ArticleCell death & disease2025
Targeting the SYVN1-EGFR axis: a breakthrough strategy for TKI-resistant NSCLC.
Xinsheng Xie et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ArticleCell death & disease2025
Xinsheng Xie et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.